Proteolysis targeting chimeras (PROTACs) are emerging therapeutics for hematologic malignancies

Yonghan He, Sajid Khan, Zhiguang Huo, Dongwen Lv, Xuan Zhang, Xingui Liu, Yaxia Yuan, Robert Hromas, Mingjiang Xu, Guangrong Zheng, Daohong Zhou

Research output: Contribution to journalReview articlepeer-review

69 Scopus citations

Fingerprint

Dive into the research topics of 'Proteolysis targeting chimeras (PROTACs) are emerging therapeutics for hematologic malignancies'. Together they form a unique fingerprint.

Medicine and Dentistry

Biochemistry, Genetics and Molecular Biology